CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitors
- PMID: 12031318
- DOI: 10.1016/s0960-894x(02)00202-0
CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitors
Abstract
The discovery, synthesis and biological activity of a series of triarylethane phosphodiesterase 4 inhibitors is described. Structure-activity relationship studies are presented for CDP840 (29), a potent, chiral, selective inhibitor of PDE 4 (IC(50) 4nM). CDP840 is non-emetic in the ferret at 30mgkg(-1) (po), active in models of inflammation and reverses ozone-induced bronchial hyperreactivity in the guinea pig.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
